This inventor holds 1 USPTO granted patent. Top assignee: Choongwae Pharma Corporation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Innovations of Woo-Young Lee in Injectable Compositions
Introduction
Woo-Young Lee is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable compositions. His work focuses on enhancing the efficacy and safety of cancer treatments.
Latest Patents
Woo-Young Lee holds a patent for an injectable composition of paclitaxel. This innovative formulation includes a solubilizer such as polyoxyl hydrogenated castor oil and anhydrous ethanol, along with a stabilizer like N-acetyl amino acid. The composition demonstrates an excellent anticancer effect, providing a medical benefit that surpasses existing formulations. It features lower toxicity and superior solubility and stability at room temperature, allowing for effective venous injection through fine particles.
Career Highlights
Woo-Young Lee is associated with Choongwae Pharma Corporation, where he continues to advance his research and development efforts. His work has the potential to significantly impact cancer treatment protocols and improve patient outcomes.
Collaborations
He collaborates with esteemed colleagues such as Sang-Heon Lee and Kye-Hyun Kim, contributing to a dynamic research environment that fosters innovation.
Conclusion
Woo-Young Lee's contributions to injectable compositions of paclitaxel highlight his commitment to improving cancer therapies. His innovative approach and collaboration with other experts in the field position him as a key figure in pharmaceutical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile